Atossa Therapeutics (ATOS) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.07
-0.06
-0.05
-0.04

Details

Expected EPS
-0.0575
Actual EPS
-0.07
Surprise EPS
-0.01
Surprise Percent
+21.74%

Description

Atossa Therapeutics (ATOS) has reported earnings of -0.07 per share for Q3 2025.

0 Comments

Share your thoughts